| 1 | Bis[(<i>S</i>)-β-phenethylammonium] tribromoplumbate(II) (10.1107/s1600536803010985) | Abstract References ORCID | 159.29 | 132 |
| 2 | Goethite, α-FeO(OH), from single-crystal data (10.1107/s1600536806047258) | Abstract References ORCID | 147.28 | 91 |
| 3 | <i>N</i>-(2-Chlorophenyl)benzenesulfonamide (10.1107/s1600536806002303) | Abstract References ORCID | 137.44 | 67 |
| 4 | Redetermination of curcumin: (1<i>E</i>,4<i>Z</i>,6<i>E</i>)… (10.1107/s160053680700222x) | Abstract References ORCID | 137.44 | 67 |
| 5 | Theophylline monohydrate (10.1107/s1600536802002921) | Abstract References ORCID | 136.47 | 65 |
| 6 | Poly[bis(phenethylammonium) [dibromidoplumbate(II)]-di-μ-bro… (10.1107/s160053680903712x) | Abstract References ORCID | 135.97 | 64 |
| 7 | CeRu<sub>2</sub>Al<sub>10</sub>with the YbFe<sub>2</sub>Al<s… (10.1107/s1600536805000310) | Abstract References ORCID | 133.36 | 59 |
| 8 | <scp>L</scp>-Cysteine-I at 30 K (10.1107/s1600536805023688) | Abstract References ORCID | 130.53 | 54 |
| 9 | 2,6-Diamino-3,5-dinitro-1,4-pyrazine 1-oxide (10.1107/s1600536801010352) | Abstract References ORCID | 126.76 | 48 |
| 10 | Gallic acid (10.1107/s1600536811000262) | Abstract References ORCID | 126.09 | 47 |
| 11 | β-Glycine (10.1107/s160053680200836x) | Abstract References ORCID | 121.74 | 41 |
| 12 | Redetermination of the β-polymorph of<i>p</i>-aminobenzoic a… (10.1107/s160053680500961x) | Abstract References ORCID | 119.33 | 38 |
| 13 | <scp>L</scp>-Serine III at 8.0 GPa (10.1107/s1600536806032508) | Abstract References ORCID | 119.33 | 38 |
| 14 | Editorial (10.1107/s1600536809051757) | Abstract References ORCID | 119.33 | 38 |
| 15 | Reinvestigation of Ni<sub>3</sub>TeO<sub>6</sub> (10.1107/s1600536806043042) | Abstract References ORCID | 117.62 | 36 |
| 16 | Hexagonal LuMnO<sub>3</sub>revisited (10.1107/s1600536801015896) | Abstract References ORCID | 116.72 | 35 |
| 17 | A phenyl-end-capped tetramer of aniline (10.1107/s1600536802002532) | Abstract References ORCID | 115.81 | 34 |
| 18 | Luteolin (10.1107/s1600536803013229) | Abstract References ORCID | 114.86 | 33 |
| 19 | Polymorphic form II of 2-methyl-4-(4-methyl-1-piperazinyl)-1… (10.1107/s160053680302806x) | Abstract References ORCID | 112.89 | 31 |
| 20 | A novel uranium-containing coordination polymer: poly[[aqua(… (10.1107/s1600536804000765) | Abstract References ORCID | 112.89 | 31 |
| 21 | 3-(2-Hydroxyphenyl)-4-phenyl-1<i>H</i>-1,2,4-triazole-5(4<i>… (10.1107/s1600536804020367) | Abstract References ORCID | 112.89 | 31 |
| 22 | Cubic phase of single-crystal LaAlO<sub>3</sub>perovskite sy… (10.1107/s1600536805020441) | Abstract References ORCID | 112.89 | 31 |
| 23 | Gallic acid monohydrate (10.1107/s1600536801012041) | Abstract References ORCID | 111.85 | 30 |
| 24 | Pentafluorophenylboronic acid (10.1107/s1600536804022408) | Abstract References ORCID | 110.78 | 29 |
| 25 | A novel uranium-containing coordination polymer: poly[dioxou… (10.1107/s1600536805009438) | Abstract References ORCID | 110.78 | 29 |
| 26 | <i>cis</i>-2,4,6,8-Tetranitro-1<i>H</i>,5<i>H</i>-2,4,6,8-te… (10.1107/s1600536802013582) | Abstract References ORCID | 109.68 | 28 |
| 27 | Redetermination of<i>para</i>-aminopyridine (fampridine, EL-… (10.1107/s1600536805010433) | Abstract References ORCID | 109.68 | 28 |
| 28 | Cu<sub>3</sub>NbS<sub>4</sub> (10.1107/s1600536805022397) | Abstract References ORCID | 109.68 | 28 |
| 29 | Redetermination of the high-pressure modification of AlOOH f… (10.1107/s160053680603916x) | Abstract References ORCID | 109.68 | 28 |
| 30 | Dichloro(η<sup>6</sup>-<i>p</i>-cymene)(triphenylphosphine)r… (10.1107/s1600536806039869) | Abstract References ORCID | 109.68 | 28 |
| 31 | <i>N</i>-Benzoylbenzenesulfonamide (10.1107/s1600536809037222) | Abstract References ORCID | 109.68 | 28 |
| 32 | PbGaBO<sub>4</sub>, an orthoborate with a new structure-type (10.1107/s1600536801013940) | Abstract References ORCID | 108.54 | 27 |
| 33 | γ-Indomethacin at 120 K (10.1107/s160053680301290x) | Abstract References ORCID | 108.54 | 27 |
| 34 | Melamine (1,3,5-triazine-2,4,6-triamine): a neutron diffract… (10.1107/s160053680403332x) | Abstract References ORCID | 108.54 | 27 |
| 35 | α-Lactose monohydrate: a redetermination at 150 K (10.1107/s1600536805021367) | Abstract References ORCID | 108.54 | 27 |
| 36 | Hexagonal ErMnO<sub>3</sub> (10.1107/s160053680100811x) | Abstract References ORCID | 107.35 | 26 |
| 37 | Bis(1,1-dimethylbiguanido)copper(II) octahydrate (10.1107/s1600536802007092) | Abstract References ORCID | 107.35 | 26 |
| 38 | <i>N</i>-Benzoyl-<i>N</i>′-phenylthiourea (10.1107/s1600536802023711) | Abstract References ORCID | 107.35 | 26 |
| 39 | Fenofibrate (10.1107/s1600536803008274) | Abstract References ORCID | 107.35 | 26 |
| 40 | Dimeric dioxocations, (NpO<sub>2</sub><sup>+</sup>)<sub>2</s… (10.1107/s1600536807002164) | Abstract References ORCID | 107.35 | 26 |
| 41 | Reinvestigation of trilithium phosphide, Li<sub>3</sub>P (10.1107/s1600536807008422) | Abstract References ORCID | 107.35 | 26 |
| 42 | <i>N</i>-(4-Bromophenyl)methanesulfonamide (10.1107/s1600536807019009) | Abstract References ORCID | 107.35 | 26 |
| 43 | A monoclinic polymorph of<i>N</i>-(3-chlorophenyl)benzamide (10.1107/s1600536810040262) | Abstract References ORCID | 107.35 | 26 |
| 44 | A seven-coordinate pyridine-2,6-dicarboxylate-bridged cadmiu… (10.1107/s1600536802009066) | Abstract References ORCID | 106.12 | 25 |
| 45 | 1-(4-Chlorophenyl)-3-(4-ethoxyphenyl)prop-2-en-1-one (10.1107/s1600536807017394) | Abstract References ORCID | 106.12 | 25 |
| 46 | <i>N</i>-(4-Fluorophenyl)methanesulfonamide (10.1107/s1600536807018491) | Abstract References ORCID | 106.12 | 25 |
| 47 | A primary monomeric alane: [<i>N</i>,<i>N</i>′-bis(2,6-diiso… (10.1107/s1600536801007413) | Abstract References ORCID | 104.85 | 24 |
| 48 | Quinoline (10.1107/s1600536801014891) | Abstract References ORCID | 104.85 | 24 |
| 49 | A 2:1 cocrystal of 6,13-dihydropentacene and pentacene (10.1107/s1600536802018445) | Abstract References ORCID | 104.85 | 24 |
| 50 | Bis(1-phenylethylammonium) tetraiodoplumbate(II) (10.1107/s1600536802019025) | Abstract References ORCID | 104.85 | 24 |